Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document
Abbott Laboratories vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?
View original at fool.comMotley Fool - Stock Analysis Title: Abbott Laboratories vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?…
What we drew from this source
The claims Via News extracted from this document. We point to the source; we don't replace it.
No single customer loss would materially hurt Abbott's business.
60% confidence